Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
COD not available
CARDIOLOGYRANGE by SACUSMART 200

Sacubitril and Valsartan Tablets 97 mg + 103 mg

INR 525 INR 750
You Save: INR 225 (30%)

Description

Product details

Description: SACUSMART 200 is a combination medicine containing Sacubitril (97 mg) and Valsartan (103 mg), specifically designed to manage chronic heart failure with reduced ejection fraction (HFrEF). This dual-acting therapy is classified as an angiotensin receptor neprilysin inhibitor (ARNI) and is widely prescribed to reduce the risk of cardiovascular death and hospitalization in patients with heart failure. Heart failure is a progressive condition where the heart cannot pump blood efficiently to meet the body’s needs. SACUSMART 200 improves the efficiency of the heart by relaxing blood vessels, reducing fluid retention, and lowering strain on the heart, helping patients live a better and longer life. What is SACUSMART 200? SACUSMART 200 is a highly effective heart failure medication that combines two active components: Sacubitril (97 mg) – a neprilysin inhibitor that increases levels of natriuretic peptides, leading to vasodilation, sodium excretion, and reduced stress on the heart. Valsartan (103 mg) – an angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and prevents harmful effects of angiotensin II. Together, these mechanisms make SACUSMART 200 a superior alternative to traditional ACE inhibitors or ARBs alone in treating chronic heart failure. Uses of SACUSMART 200 SACUSMART 200 is prescribed for: Chronic heart failure with reduced ejection fraction (HFrEF) Reducing risk of hospitalization due to worsening heart failure Improving survival rates in patients with heart failure Enhancing exercise tolerance and quality of life in long-term heart failure management Benefits of SACUSMART 200 Dual action with neprilysin inhibition + ARB effect for comprehensive heart protection Proven to reduce mortality and hospitalization risk in heart failure patients Improves symptoms such as breathlessness, fatigue, and swelling Helps patients regain better physical stamina and daily activity levels Long-term use significantly contributes to improved quality of life Possible Side Effects of SACUSMART 200. While SACUSMART 200 is effective and generally well tolerated, some patients may experience: Low blood pressure (hypotension) Increased blood potassium levels (hyperkalemia) Dizziness or light-headedness Kidney function changes Cough Rarely, serious allergic reactions or angioedema (swelling of face, lips, or throat) Immediate medical attention is required if severe swelling, difficulty breathing, or fainting occurs. Precautions Before Using SACUSMART 200. Do not use if you are allergic to sacubitril, valsartan, or other ARBs Avoid if you have taken an ACE inhibitor within the last 36 hours due to the risk of angioedema Not recommended for patients with a history of hereditary angioedema Caution in patients with severe kidney or liver disease Pregnant and breastfeeding women should avoid this medicine due to harmful effects on the baby Always monitor blood pressure, kidney function, and potassium levels while on this treatment Drug Interactions. SACUSMART 200 may interact with: ACE inhibitors – should not be combined, risk of angioedema Potassium supplements or potassium-sparing diuretics – risk of high potassium NSAIDs (e.g., ibuprofen, naproxen) – may reduce kidney function Lithium – risk of lithium toxicity Diuretics – may increase the risk of low blood pressure Always inform your doctor about all medicines, supplements, or herbal products you are taking before starting SACUSMART 200. Conclusion SACUSMART 200 (Sacubitril 97 mg & Valsartan 103 mg) is a breakthrough treatment in managing chronic heart failure with reduced ejection fraction (HFrEF). By combining neprilysin inhibition and angiotensin receptor blockade, it not only reduces symptoms but also significantly lowers the risk of hospitalization and death, improving both longevity and quality of life. For patients living with heart failure, SACUSMART 200 offers a scientifically proven and clinically superior solution to regain control over their health and live a more fulfilling life.

Other Specifications

Counrty :India
Storage :Store In A Cool & Dry Place
Package SIZE : FOR 10 TABLETS
Manufactured By :Steris Healthcare Pvt Ltd
Brand Name :SACUSMART 200
  • Filter tags

Have any question or need any business consultation?

Have any question or need any business consultation?

Contact Us
Chat with us